Details

Autor(en) / Beteiligte

• Li, Zhi
• Cui, Jiuwei

Titel

Targeting the lactic acid metabolic pathway for antitumor therapy

Ist Teil von

• Molecular therapy. Oncolytics, 2023-12, Vol.31, p.100740-100740, Article 100740

Ort / Verlag

Elsevier Inc

Erscheinungsjahr

2023

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Lactic acid is one of the most abundant products of cellular metabolism and has historically been considered a cell-damaging metabolic product. However, as research has deepened, the beneficial effects of lactic acid on tumor cells and the tumor microenvironment have received increasing attention from the oncology community. Lactic acid can not only provide tumor cells with energy but also act as a messenger molecule that promotes tumor growth and progression and protects tumor cells from immune cells and killing by radiation and chemotherapy. Thus, the inhibition of tumor cell lactic acid metabolism has emerged as a novel antitumor treatment strategy that can also effectively enhance the efficacy of conventional antitumor therapies. In this review, we classify the currently available therapies targeting lactic acid metabolism and examine their prospects for clinical application. [Display omitted] Lactic acid is important for tumor progression and survival, and using lactic acid metabolism to treat tumors has become a research hotspot recently. In this review, Li and Cui summarize the rationale and strategies in targeting tumor lactic acid metabolism therapy, with a focus on clinical and preclinical evidence.